Blue Crest Capital Management LTD Moderna, Inc. Transaction History

Blue Crest Capital Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $351,390 - $529,770	-3,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $379,380 - $705,150	3,000 New	3,000 $517,000
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $554,594 - $968,039	-10,206 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $302,812 - $816,480	10,206 New	10,206 $655,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.